First prescription obesity drug in more than a decade struggles to sell
Just a few years ago, a drug company CEO predicted anti-obesity pills could rival the sales of drugs like Lipitor. Instead, the first prescription diet pill to arrive in 13 years is barely selling, the New York Times
reports. Qsymia maker Vivus spent $45 million to promote the drug in...